Gilead Sciences | Handelsfordringar



Trade Creditors Ändra Datum
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 197.46M 18.76M 2024-12
J&J USD 10.31B 1.36B 2024-12
Merck USD 4.08B 493M 2024-12
Moderna USD 405M 32M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
PTC Therapeutics USD 17.27M 3.98M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Sanofi 7.43B 105M 2024-06
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
United Therapeutics 6M 357.9M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Gilead Sciences Handelsfordringar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.